Company Registration No. 07085437 (England and Wales)
Imaan Pharma Ltd
Filleted accounts
for the period from 1 December 2022 to 31 July 2023
Imaan Pharma Ltd
Filleted accounts
Contents
Imaan Pharma Ltd
Company Information
for the period from 1 December 2022 to 31 July 2023
Directors
Mr A Qayum
Mr E Qayum
Company Number
07085437 (England and Wales)
Registered Office
50 Gregory Boulevard
Nottingham
NG7 5JD
Accountants
YP Finance
Hawthorne House
17A Hawthorne Drive
Leicester
Leicestershire
LE5 6DL
Imaan Pharma Ltd
Statement of financial position
as at 31 July 2023
Cash at bank and in hand
67,700
30,734
Creditors: amounts falling due within one year
(102,259)
(102,247)
Net current assets
83,006
159,339
Called up share capital
104
104
Profit and loss account
82,902
159,235
Shareholders' funds
83,006
159,339
For the period ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 31 July 2024 and were signed on its behalf by
Mr E Qayum
Director
Company Registration No. 07085437
Imaan Pharma Ltd
Notes to the Accounts
for the period from 1 December 2022 to 31 July 2023
Imaan Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 07085437. The registered office is 50 Gregory Boulevard, Nottingham, NG7 5JD.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Fixtures & fittings
20% straight line
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
Imaan Pharma Ltd
Notes to the Accounts
for the period from 1 December 2022 to 31 July 2023
4
Tangible fixed assets
Fixtures & fittings
Amounts falling due within one year
Trade debtors
84,081
165,517
6
Creditors: amounts falling due within one year
2023
2022
Trade creditors
75,635
69,353
Taxes and social security
-
3,770
Other creditors
1,637
4,137
Loans from directors
23,816
23,816
Allotted, called up and fully paid:
100 A Ordinary shares of £1 each
100
100
4 B Ordinary Shares of £1 each
4
4
8
Transactions with related parties
Imaan Pharma Ltd is renting its premises from Mr A Qayum and Mr E Qayum at a market rent of £12,600 (2021 - £12,171) per annum. Mr A Qayum and Mr E Qayum hold controlling interests in Imaan Pharma Ltd.
9
Average number of employees
During the period the average number of employees was 9 (2022: 9).